Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s
Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities
Market Price for Equity Securities
Our common stock is quoted on
the OTC Pink under the symbol “DWAY”. The following table sets forth the quarterly high and low daily close for our common
stock for the two years ended September 30, 2024 and 2023. There is a very limited market for the Company’s common stock
Price Range
High
Low
Year ended September 30, 2024
First Quarter
$ 0.10
$ 0.0004
Second Quarter
$ 0.11
$ 0.0025
Third Quarter
$ 0.09
$ 0.02
Fourth Quarter
$ 0.11
$ 0.04
Year ended September 30, 2023
First Quarter
$ 0.13
$ 0.03
Second Quarter
$ 0.13
$ 0.02
Third Quarter
$ 0.04
$ 0.02
Fourth Quarter
$ 0.04
$ 0.00
Holders
At
February 24, 2025 , the Company had 113,951,722 outstanding
shares of common stock and 143 shareholders of record.
9
Dividends
Holders of common stock are entitled
to receive dividends as may be declared by the Company’s Board. The Company’s Board is not restricted from paying any dividends
but is not obligated to declare a dividend. No dividends have ever been declared, and it is not anticipated that dividends will be paid
in the foreseeable future. Any indebtedness the Company incurs in the future may also limit its ability to pay dividends. Investors should
not purchase the Company’s common stock with the expectation of receiving cash dividends.
Recent Sales of Unregistered Securities
In May 2024, the Company issued 750,000 shares of
its common stock to an accredited investor for $15,000 in gross proceeds. The issuance to the investor relied on the exemption from registration provided
by Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted
stock.
In May 2024, the Company issued 1,000,000 shares of its common stock to a
lender as a commitment fee. The fair market value of the common stock on the date of grant was $70,000. The issuance to the investor relied
on the exemption from registration provided by Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation
D promulgated thereunder concerning the issuance of restricted
stock.
In July 2024, the Company issued 400,000 shares of
its common stock to four accredited investors for $8,000 in gross proceeds. The issuance to the investor relied on the exemption from registration provided
by Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted
stock.
On July 12, 2024, the Company sold a warrant to purchase
5,000,000 shares of the Company’s common stock at an exercise price of $0.00001 to an investor for $50,000. The warrant has no expiration
date. The investor has the option of funding the Company with two additional tranches of $50,000. The second tranche of $50,000 is due
within 60 days of the first funding date of July 12, 2024.
On August 19, 2024, the Company received the funding
for the second tranche and issued to the investor a cash warrant to purchase up to 666,666 shares of Common Stock at an exercise price
of $0.08 per share. The warrant has no expiration date.
In November 2024, the Company issued 250,000 shares
of its common stock to an accredited investor for $5,000 in gross proceeds. The issuance to the investor relied on the exemption from registration provided
by Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted
stock.
At any time 90 days after the second tranche funding
date the investor may invest an additional $50,000 and the Company will issue to the investor a pre-funded warrant to purchase up to 2,500,000
shares of Common Stock in the and a cash warrant to purchase up to 333,333 shares of Common Stock at an exercise price of $0.08 per share.
The warrant does not have an expiration date.
The issuance to the investor relied on the exemption from registration provided
by Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted
stock.
Purchase of Equity Securities by the Issuer
and Affiliated Purchasers
We did not repurchase any securities
during the fiscal year ended September 30, 2024.
Item 6. Selected Financial Data
As a smaller reporting company,
we are not required to provide the information required by this Item.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.